NEU neuren pharmaceuticals limited

Ann: Q2 2023 quarterly activity and cash flow report, page-6

  1. 293 Posts.
    lightbulb Created with Sketch. 88
    NEU posted a great quarterly, yet ASX is still not rewarding it properly. The lack of broader understanding of this stock amongst institutional investors in Australia is astounding. If NEU was listed in the US it would be highly rated. Petra's analyst noted RETA's takeover last week in today's NEU update. It gives a comparison between NEU and RETA. RETA for reference is being taken over at US$7.3bn or A$10bn+. Quite astronomical valuation differences.

    https://hotcopper.com.au/data/attachments/5469/5469591-fd42b2fe5fa0fdabb4942fc21850e05b.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.26
Change
-0.280(2.23%)
Mkt cap ! $1.525B
Open High Low Value Volume
$12.45 $12.45 $11.88 $6.952M 570.0K

Buyers (Bids)

No. Vol. Price($)
1 231 $12.26
 

Sellers (Offers)

Price($) Vol. No.
$12.32 1979 2
View Market Depth
Last trade - 16.13pm 23/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.